Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abbott has received approval from the FDA for its fully automated HTLV-I/HTLV-II blood screening test for use on the Abbott Prism instrument.
Subscribe to our email newsletter
The test is intended for use by laboratories to screen individual donations of blood and plasma for antibodies to human T-lymphotropic virus type I and/or human T-lymphotropic virus type II (anti-HTLV-I/HTLV-II).
Robert Doss, divisional vice president, diagnostics R&D, Abbott, said: “With the Abbott Prism system, we continue to support the infectious disease testing needs of the laboratory while helping them realize greater efficiencies and enhanced operator safety throughout the blood and plasma screening process.”